Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis.
Saved in:
| Title: | Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis. |
|---|---|
| Authors: | Ye C; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.; Institute of Nephrology, Peking University, Beijing, China.; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Li ZY; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.; Institute of Nephrology, Peking University, Beijing, China.; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China., Han XY; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.; Institute of Nephrology, Peking University, Beijing, China.; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China., Zhao MH; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.; Institute of Nephrology, Peking University, Beijing, China.; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China., Chen M; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.; Institute of Nephrology, Peking University, Beijing, China.; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.; State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 13; Vol. 17, pp. 1787558. Date of Electronic Publication: 2026 May 13 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1787558 |
